New care model closes significant gap in addiction treatment

November 8, 2017, Boston Medical Center
Credit: CC0 Public Domain

A new program at Boston Medical Center's Grayken Center for Addiction is showing that connecting patients to addiction treatment when they are hospitalized for other conditions can be a powerful tool in closing a gap in addiction treatment. In fact, early results show that many of these patients continue treatment after they are discharged, underscoring the importance of reaching patients who might otherwise not get treatment for their addiction.

Approximately 17 percent of admitted at BMC have an active substance use disorder. This led providers to look for new ways to engage patients in when they were already here. To accomplish this, they developed and implemented an inpatient consult service, which is staffed by a multidisciplinary care team with expertise in treating addiction.

"In order to help curb the epidemic, we need to take every opportunity to engage patients with substance use disorders and get them into treatment when they are ready," said study lead author Paul Trowbridge, MD, and graduate of BMC's addiction medicine fellowship. "This service will not only prove beneficial to patients, by helping them get access to evidenced-based treatment, but also to the health care system by reducing costs and readmissions."

Researchers found the initial results promising: Methadone treatment was initiated for 70 patients and 76 percent were linked to a methadone clinic upon discharge. Upon follow up, 54 percent were still receiving methadone at 30 days, 39 percent at 90 days, and 29 percent at 180 days. Buprenorphine was initiated in 40 patients as a result of the consult, and 49 percent were linked to an outpatient clinic at discharge. Upon follow up, 39 percent were still engaged in treatment at 30 days, 27 percent at 90 days and 18 percent at 180 days.

"Like heart disease can cause a heart attack or a stroke, addiction causes many acute injuries requiring immediate attention, but we can't simply treat that issue without delving deeper to address the root cause," said Alex Walley, MD, MSc, a general internist at BMC's Grayken Center for Addiction who also oversees the addiction medicine fellowship. "Our goal is to engage willing patients in treatment and work with them on a plan that will keep them healthy and safe now and in the future."

The authors note that treatment is not one size fits all and that there is a need for additional programs and services that meet the needs of even more patients both in the short and long term.

This study was published in the Journal of Substance Abuse Treatment.

Explore further: Starting opioid addiction treatment in the ED is cost-effective

Related Stories

Starting opioid addiction treatment in the ED is cost-effective

August 16, 2017
The most cost-effective treatment for people with untreated opioid addiction who visit the emergency department (ED) is buprenorphine, a medication to reduce drug cravings and withdrawal, say Yale researchers. Their study ...

Treat patients with addiction during, after hospitalization, researchers say

June 30, 2014
The results of a new study demonstrate that starting hospitalized patients who have an opioid (heroin) addiction on buprenorphine treatment in the hospital and seamlessly connecting them with an outpatient office based treatment ...

Longer addiction treatment is better, study confirms

March 4, 2017
(HealthDay)—The longer patients receive treatment for addiction, the greater their chances of success, a new study finds.

Who should treat patients with opioid use disorder?

July 11, 2017
In a Point/Counterpoint, two doctors debate whether or not family physicians should provide medication-assisted treatment to their patients with opioid use disorder.

Primary care-based addiction treatment lowers substance dependence in people with HIV

September 29, 2015
A program developed at Boston Medical Center (BMC), which integrates addiction treatment into primary care for patients with or at risk for HIV, has been shown to lower patients' substance dependence and encourage their engagement ...

Patients with opioid addiction benefit from treatment initiated in ED

February 14, 2017
Patients addicted to opioids often seek care in the emergency department (ED). They are more likely to receive addiction treatment, and reduce opioid use long-term if they are started on medication to reduce cravings in the ...

Recommended for you

Low academic achievement can lead to drug abuse decades later, research finds

September 13, 2018
A Virginia Commonwealth University researcher has found that poor academic achievement can lead to substance abuse. Data collected from Swedish participants over a period of 15 to 20 years indicate a strong correlation.

Cocaine addiction traced to increase in number of orexin neurons

September 12, 2018
A study in cocaine-addicted rats reports long-lasting increases in the number of neurons that produce orexin—a chemical messenger important for sleep and appetite—that may be at the root of the addiction. The study, performed ...

Single-step nasal spray naloxone easiest to deliver according to new research

August 29, 2018
Single-step nasal spray naloxone is the easiest to deliver, according to new research led by faculty at Binghamton University, State University at New York.

Scientists identify 35 genes associated with cannabis use

August 28, 2018
A large-scale genetic study found that some of the same genes associated with the use of cannabis are also associated with certain personality types and psychiatric conditions. The study, published in Nature Neuroscience, ...

SMURF1 provides targeted approach to preventing cocaine addiction relapse

August 14, 2018
A class of proteins that has generated significant interest for its potential to treat diseases, has for the first time, been shown to be effective in reducing relapse, or drug-seeking behaviors, in a preclinical study.

Cocaine relapse is reversed with BDNF microinjections in the brain

August 3, 2018
Cocaine relapse was significantly reduced in a preclinical model when brain-derived neurotropic factor (BDNF) was applied to the nucleus accumbens deep in the brain immediately before cocaine-seeking behavior, report investigators ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.